Skip to main content
. 2024 Oct 18;25(20):11220. doi: 10.3390/ijms252011220

Table 2.

Eligibility criteria.

Inclusion Criteria
  • -

    English language

  • -

    Reference period from inception to 31 May 2024

  • -

    Study design: preclinical and clinical studies, including case reports, clinical trials, comparative studies, and observational studies

  • -

    Studies investigating the effects of magnesium on skeletal muscle tissue

  • -

    Studies including use of magnesium as supplementation for patients with inherited neuromuscular disease

Exclusion Criteria
  • -

    Books and documents, meta-analyses, reviews, systematic reviews, letters to the editor

  • -

    Articles written in other languages.

  • -

    Studies investigating use of magnesium in acquired neuromuscular disease

  • -

    Studies investigating any kind of use of magnesium not as supplementation and/or treatment for muscle